Sample size for a non-inferiority clinical trial with time-to-event data in the presence of competing risks

28 Feb 2018 Han Dong Chen Zheng Hou Yawen

The analysis and planning methods for competing risks model have been described in the literatures in recent decades, and non-inferiority clinical trials are helpful in current pharmaceutical practice. Analytical methods for non-inferiority clinical trials in the presence of competing risks were investigated by Parpia et al., who indicated that the proportional sub-distribution hazard model is appropriate in the context of biological studies... (read more)

PDF Abstract
No code implementations yet. Submit your code now




  Add Datasets introduced or used in this paper